Document ID: chunk:federal_register_of_legislation:F2019L00252:reg:9:p1
Version: federal_register_of_legislation:F2019L00252
Segment Type: reg
Provision Reference: reg 9 (pt 1/2)
Character Range: 3274–6101

9               Factors that must exist
At least one of the following factors must exist before it can be said that, on the balance of probabilities, blepharitis or death from blepharitis is connected with the circumstances of a person's relevant service:
(1)          having an infection of the affected eyelid at the time of the clinical onset of blepharitis;
Note: infection of the affected eyelid is defined in the Schedule 1 - Dictionary.
(2)          having an infestation of the affected eyelid region, due to a parasite from the specified list of parasites, at the time of the clinical onset of blepharitis;
Note: specified list of parasites is defined in the Schedule 1 - Dictionary.
(3)          having a smallpox immunisation within the two weeks before the clinical onset of blepharitis;
(4)          having seborrhoeic dermatitis of the periocular region at the time of the clinical onset of blepharitis;
(5)          having rosacea of the periocular region at the time of the clinical onset of blepharitis;
(6)          having psoriasis of the periocular region at the time of the clinical onset of blepharitis;
(7)          having discoid lupus erythematosus of the periocular region at the time of the clinical onset of blepharitis;
(8)          having ocular or periocular exposure to an allergen within the 48 hours before the clinical onset of blepharitis;
Note: allergen is defined in the Schedule 1 - Dictionary.
(9)           having an irritant substance exposure to the region of the affected eye at the time of the clinical onset of blepharitis;
Note: irritant substance is defined in the Schedule 1 - Dictionary.
(10)      having mustard gas exposure to the region of the affected eye at the time of the clinical onset of blepharitis;
(11)      undergoing a course of therapeutic radiation for cancer, where the region of the affected eye was in the field of radiation, at the time of the clinical onset of blepharitis;
(12)      having a benign or malignant neoplasm affecting the affected eyelid at the time of the clinical onset of blepharitis;
(13)      having dry eye disease at the time of the clinical onset of blepharitis;
Note: dry eye disease is defined in the Schedule 1 - Dictionary.
(14)      being in an immunocompromised state as specified at the time of the clinical onset of blepharitis;
Note: immunocompromised state as specified is defined in the Schedule 1 - Dictionary.
(15)      taking oral isotretinoin or oral acitretin for a continuous period of at least one year before the clinical onset of blepharitis, and where treatment has ceased, the clinical onset of blepharitis has occurred within 30 days of cessation;
(16)      having an infection of the affected eyelid at the time of the clinical worsening of blepharitis;
Note: infection of the affected eyelid is defined in the